Clinical trial

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

NCT00004174

Study summary

ClinicalTrials.gov

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention filgrastim Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cyclophosphamide Normalized identity: cyclophosphamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record thiotepa Normalized identity: thiotepa View linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention peripheral blood stem cell transplantation Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-10-01

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

filgrastimBIOLOGICAL

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

paclitaxelDRUG · verified · RxNorm: paclitaxel

thiotepaDRUG · verified · RxNorm: thiotepa

peripheral blood stem cell transplantationPROCEDURE

radiation therapyRADIATION

Sponsors & collaborators

Northwestern Universitylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00004174 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.